WEH Westcoast Hosp Cp

ResMed Appoints Two Independent Directors Board of Directors Expanded to Eight Members SAN DIEGO, Jan. 25 /PRNewswire-FirstCall/ -- ResMed Inc (NYSE:RMD) announced that, effective today, it has appointed to its board of directors Mr. John Wareham, Chairman and Chief Executive Officer of Beckman Coulter, and Mr. Ron Taylor, founder of Pyxis Corporation. Louis Simpson has resigned from the board. "Lou has been a tremendous asset to our board since he joined in 2002. While I am sorry to see him go, I am grateful for his contributions despite the increasing demands on his time," stated Peter C. Farrell, PhD, Chairman and Chief Executive Officer. "I look forward to working with Jack and Ron, who both bring a wealth of health care experience to the board. I have admired their ability to deliver results at their respective companies." John Wareham is Chairman and Chief Executive Officer of Beckman Coulter, Inc. (NYSE:BEC). Before joining Beckman Coulter in 1984, Mr. Wareham was President of Norden Laboratories, Inc., a wholly-owned subsidiary of SmithKline Beckman. He first joined a predecessor of SmithKline Beckman Corporation in 1968. Mr. Wareham is a director of STERIS Corporation (NYSE:STE) and Wilson Greatbatch Technologies, Inc. (NYSE:GB). He is also a director and past Chairman of AdvaMed, the Advanced Medical Technology Association, a member of the Board of Trustees of the Manufacturers Alliance/MAPI, the National Association of Manufacturers, and the California Healthcare Institute. He is also on the advisory board of the John Henry Foundation, a member of the Center for Corporate Innovation, a member of the Chief Executive Roundtable of the University of California, Irvine, and a member of the Advisory Council of the Keck Graduate Institute of Applied Life Sciences. Mr. Wareham holds a B.S. in Pharmacy from Creighton University in Omaha, Nebraska, and an MBA from Washington University in St. Louis, Missouri. Ron Taylor is a director of Watson Pharmaceuticals, Inc. (NYSE:WPI) and WestCoast Hospitality Corporation (NYSE:WEH) and is Chairman of the Board of three privately-held companies: 3E Company, EMN8 Corporation, and Asteres, Inc. Mr. Taylor is also a member of the Board of Trustees of San Diego Museum of Contemporary Art and is Chairman of the University of California, San Diego Foundation. Beginning in 2002, he also served as chair of the ResMed Foundation, although in connection with his appointment to the Board of Directors, he has resigned from the Foundation board. In 1987, Mr. Taylor founded Pyxis Corporation where he served as Chairman, President, and Chief Executive Officer until its purchase by Cardinal Health, Inc., in 1996. Before founding Pyxis, Mr. Taylor was responsible for the operations and international sales at Hybritech, Inc., for six years. Before joining Hybritech, he served over ten years in management roles at Allergan Pharmaceuticals. Mr. Taylor received a B.A. from the University of Saskatchewan and an M.A. from the University of California, Irvine. About ResMed ResMed is a leading manufacturer of medical equipment for the diagnosis, treatment, and management of sleep-disordered breathing, which is estimated to affect approximately 43 million Americans. We are dedicated to improving awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing and to developing innovative technology to improve the lives of those who suffer from this condition. For more information on ResMed, visit http://www.resmed.com/. DATASOURCE: ResMed Inc CONTACT: Hillary Theakston, Director of Investor Relations of ResMed Inc, +1-858-746-2610, Web site: http://www.resmed.com/

Copyright